Supernus Pharmaceuticals, Inc. (LON:0LB2)
London flag London · Delayed Price · Currency is GBP · Price in USD
33.25
+0.84 (2.59%)
At close: Jul 10, 2025

Supernus Pharmaceuticals Market Cap

Supernus Pharmaceuticals has a market cap or net worth of 1.53 billion as of July 11, 2025. Its market cap has increased by 31.26% in one year.

Market Cap
1.53B
Enterprise Value
1.21B
Revenue
517.02M
Ranking
n/a
PE Ratio
31.93
Stock Price
33.25

Market Cap Chart

Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 1.53B, an increase of 1,832.54%. That is a compound annual growth rate of 25.15%.

History

DateMarket Cap% Change
Jul 10, 20251.53B-4.07%
Dec 31, 20241.59B28.49%
Dec 29, 20231.24B-22.44%
Dec 30, 20221.60B39.74%
Dec 31, 20211.15B17.96%
Dec 31, 2020970.89M3.33%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 164.77B
GSK plc 58.85B
Haleon 33.44B
Smith & Nephew 10.11B
ConvaTec Group 5.40B
Hikma Pharmaceuticals 4.40B
HUTCHMED (China) 1.98B
Oxford Nanopore Technologies 1.47B
Market Cap Rankings